Literature DB >> 22426704

A cohort-controlled trial of the addition of customized foot orthotics to standard care in fibromyalgia.

Robert Ferrari1.   

Abstract

Customized foot orthotics are widely prescribed for patients with chronic, non-specific low back pain and lower limb pain, but there are few trials demonstrating effectiveness, and none for fibromyalgia. A total of 67 consecutive patients presenting with chronic, widespread pain, who met the 1990 American College of Rheumatology criteria for fibromyalgia, were included in the study. A total of 32 subjects were prescribed a spinal exercise therapy program along with analgesics. These subjects formed the Control group. A second group, comprised of 35 subjects, received the same therapy, along with customized foot orthotics (Orthotics group). All subjects completed the Revised Fibromyalgia Impact Questionnaire (FIQR) at the initiation of the study and at 8 weeks follow-up. The number of subjects using any type of prescription analgesic or other medication for chronic pain at baseline and at 8 weeks was also recorded. A total of 30 subjects in the Control group and 33 in the Orthotics group completed the study. All subjects completed the baseline and 8-week FIQR. The two groups were well matched in terms of age (45.3 ± 11.5 years in the Orthotics group vs. 47.2 ± 8.7 years in the cohort Control), medication use, duration of pain (6.5 ± 4.3 years in the Orthotics group vs. 6.2 ± 3.4 years in the cohort Control group), as well as baseline FIQR scores (55.2 ± 11.0 in the Orthotics group vs. 56.3 ± 12.2 in the cohort Control group). At 8 weeks, the Orthotics group had a greater reduction in the FIQR score than the cohort Control group (reduction of 9.9 ± 5.9 vs. 4.3 ± 4.4, respectively), and this was mainly due to changes in the 'function' domain of the FIQR (reduction of 19.6 ± 9.4 in the Orthotics group vs. 8.1 ± 4.3 in the cohort Control group). As part of a complex intervention, in a cohort-controlled trial of primary care patients with fibromyalgia, the addition of custom-made foot orthotics to usual care appears to improve functioning in the short term.

Entities:  

Mesh:

Year:  2012        PMID: 22426704     DOI: 10.1007/s10067-012-1966-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Optimum position of metatarsal pad in metatarsalgia for pressure relief.

Authors:  Wei-Li Hsi; Jiunn-Horng Kang; Xin-Xian Lee
Journal:  Am J Phys Med Rehabil       Date:  2005-07       Impact factor: 2.159

2.  Effect of metatarsal pad placement on plantar pressure in people with diabetes mellitus and peripheral neuropathy.

Authors:  Mary K Hastings; Michael J Mueller; Thomas K Pilgram; Donovan J Lott; Paul K Commean; Jeffrey E Johnson
Journal:  Foot Ankle Int       Date:  2007-01       Impact factor: 2.827

3.  An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.

Authors:  Lynne Pauer; Andreas Winkelmann; Pierre Arsenault; Anders Jespersen; Laurence Whelan; Gary Atkinson; Teresa Leon; Bernhardt Zeiher
Journal:  J Rheumatol       Date:  2011-10-01       Impact factor: 4.666

4.  Shoe orthotics for the treatment of chronic low back pain: a randomized controlled pilot study.

Authors:  Jerrilyn A Cambron; Manuel Duarte; Jennifer Dexheimer; Thomas Solecki
Journal:  J Manipulative Physiol Ther       Date:  2011-05-05       Impact factor: 1.437

5.  The effect of foot wedging on electromyographic activity in the erector spinae and gluteus medius muscles during walking.

Authors:  Adam R Bird; Andrew P Bendrups; Craig B Payne
Journal:  Gait Posture       Date:  2003-10       Impact factor: 2.840

6.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

7.  Changes in gait economy between full-contact custom-made foot orthoses and prefabricated inserts in patients with musculoskeletal pain: a randomized clinical trial.

Authors:  Leslie C Trotter; Michael Raymond Pierrynowski
Journal:  J Am Podiatr Med Assoc       Date:  2008 Nov-Dec

8.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02

9.  Responsiveness of the short-form 36 and oswestry disability questionnaire in chronic nonspecific low back and lower limb pain treated with customized foot orthotics.

Authors:  Robert Ferrari
Journal:  J Manipulative Physiol Ther       Date:  2007 Jul-Aug       Impact factor: 1.437

10.  Correlations between subjective treatment responses and plantar pressure parameters of metatarsal pad treatment in metatarsalgia patients: a prospective study.

Authors:  Jiunn-Horng Kang; Min-Der Chen; Shih-Ching Chen; Wei-Li Hsi
Journal:  BMC Musculoskelet Disord       Date:  2006-12-05       Impact factor: 2.362

  10 in total
  4 in total

1.  Fibromyalgia Impact and Mindfulness Characteristics in 4986 People with Fibromyalgia.

Authors:  Kim D Jones; Scott D Mist; Marie A Casselberry; Ather Ali; Michael S Christopher
Journal:  Explore (NY)       Date:  2015-04-28       Impact factor: 1.775

Review 2.  Practice-audit-publish: A practice reflection.

Authors:  Robert Ferrari
Journal:  Eur J Rheumatol       Date:  2016-01-29

3.  Quality of life related to foot health status in women with fibromyalgia: a case-control study.

Authors:  Patricia Palomo-López; César Calvo-Lobo; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; David Rodriguez-Sanz; Rubén Sánchez-Gómez; Daniel López-López
Journal:  Arch Med Sci       Date:  2018-07-10       Impact factor: 3.318

4.  Influence of multidisciplinary therapeutic approach on fibromyalgia patients.

Authors:  Simona Pătru; Rodica Pădureanu; Florentina Dumitrescu; Vlad Pădureanu; Dumitru Rădulescu; Diana Dragoi; Daniela Matei
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.